Skip to main content
Premium Trial:

Request an Annual Quote

Chiral Technologies Acquires Arbor Biosciences

NEW YORK (GenomeWeb) — Chiral Technologies said today that it has acquired next-generation sequencing and synthetic biology products provider Arbor Biosciences.

Arbor's portfolio includes custom DNA microarrays and oligonucleotide libraries, as well as its myBaits line of targeted sequencing panels. The company also offers a cell-free protein expression kit and custom, error-free DNA templates for the transcription of guide RNAs for CRISPR research.

According to Chiral, Arbor will continue to operate at its current location in Ann Arbor, Michigan and will retain its entire team. It will operate as a wholly owned subsidiary of Japan's Daicel, Chiral's parent firm. Additional terms of the acquisition were not disclosed.

"As we diversify our product portfolio to serve the needs of biopharma, Arbor Biosciences delivers the molecular biology foundation to fuel that growth," Chiral President Joseph Barendt said in a statement.

West Chester, Pennsylvania-based Chiral also acquired DNA purification firm Diffinity Genomics in 2015.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.